Pharmaceutical distributor Hyphens Pharma has a unique game plan that involves growing its proprietary brands segment by growing its offerings of beauty and personal care products. 

The company is doing this through its recent acquisition of CG 210 – a brand carried by the Switzerland-based Legacy Healthcare – to provide products that address hair loss.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.

Bonus:

  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply

Subscribe

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook